Anavex Life Sciences financial statements

애너벡스 라이프 사이언시스NASDAQ:AVXL · Nasdaq · Healthcare · sector #16
$1.60-2.74%
2026-10-06 close · prelim

Anavex Life Sciences's published financial data is dated 2026-10-04. 2025 revenue was $0M. 2025 operating profit was −$51M.

Reported results

Anavex Life Sciences notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q